(Press-News.org) Patients with autoimmune rheumatic diseases, which include rheumatoid arthritis and other chronic disorders that cause inflammation, are at increased risk of SARS-CoV-2 infection, as well as death due to severe COVID-19. Many patients receive disease-modifying antirheumatic drugs (DMARDs) to treat these conditions, but this treatment has been associated with a blunted response to COVID-19 vaccines. The U.S. Centers for Disease Control and Prevention recommends that patients receiving DMARDs receive a fourth dose of the mRNA vaccine in addition to the three-dose primary series to protect against COVID-19.to protect against COVID-19. A new study led by Mass General Brigham researchers suggests that this recommendation saved lives and reduced hospitalizations among patients in this high-risk group. Results are published in The Lancet Rheumatology.
To conduct their study, the researchers used observational data from the Mass General Brigham healthcare system to compare rheumatic patients taking DMARDs who received a fourth dose of the mRNA vaccine to those who did not. The study included data from 4,305 patients. They found that patients who received the fourth dose had a 41 percent reduction in risk for infection and 65 percent reduction for admission/death compared to those who did not.
“A fourth dose of COVID-19 mRNA vaccine provides considerable protection against any SARS-CoV-2 infection and severe COVID-19 among patients with systemic autoimmune rheumatic diseases using DMARDs,” said co-corresponding author Zachary Wallace, MD, MSc, of the Division of Rheumatology, Immunology and Allergy at Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham healthcare system. “These patients should be encouraged to stay up-to-date with COVID-19 mRNA vaccines, including boosters after the primary vaccination series.”
Since the beginning of the pandemic, researchers from across Brigham and Women’s Hospital (BWH) and MGH have been working together to give special attention to this group of patients to find insights that could help inform their treatment as well as the care of broader patient populations.
“At the very beginning of the pandemic, we joined forces to identify every rheumatic disease patient with COVID seen at our institutions so that we could follow their clinical course and collect survey and blood data,” said co-corresponding author Jeffrey Sparks, MD, MMSc, of the Division of Rheumatology, Inflammation, and Immunity at BWH. “Working together, we are finding important clues that could help better protect patients from infection and severe disease.”
Authorship: Additional Mass General Brigham authors include Jennifer S Hanberg (BWH), Xiaoqing Fu (BWH, MGH), Xiaosong Wang (BWH), Naomi J Patel (BWH, MGH), Yumeko Kawano (BWH, MGH), Abigail Schiff (BWH), Emily N Kowalski (BWH), Claire E Cook (MGH), Kathleen M M Vanni (BWH), Krishan Guzzo (MGH), Grace Qian (BWH), Katarina J Bade (BWH), Alene Saavedra (BWH), Rathnam Venkat (BWH), Shruthi Srivatsan (MGH), and Yuqing Zhang (MGH).
Disclosures: NJP reports consulting fees from FVC Health and Alosa Health. JAS reports grant funding from Bristol Myers Squibb, the National Institute of Arthritis and Musculoskeletal and Skin Disease, the R Bruce and Joan M Mickey Research Scholar Fund, and the Llura Gund Award for Rheumatoid Arthritis Care and Research; and consulting fees from AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Gilead, Janssen, Optum, Pfizer, ReCor, and Inova Diagnostics. ZSW reports funding from the National Institutes of Health and National Institute of Arthritis and Musculoskeletal and Skin Disease for the present manuscript; grants or contracts from Bristol Myers Squibb and Principia/Sanofi; consulting fees from Viela Bio, Zenas BioPharma, BioCryst, Horizon, Sanofi, and MedPace; and advisory board participation for Sanofi, Novartis, Shionogi, Otsuka/Visterra, and Horizon.
Funding: The National Institutes of Health and the National Institute of Arthritis and Musculoskeletal and Skin Diseases
Paper cited: Hanberg JS et al. “Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trial” Lancet Rheumatology DOI: 10.1016/S2665-9913
END
Fourth dose of COVID vaccine boosts protection in patients with rheumatic disease
2023-11-15
ELSE PRESS RELEASES FROM THIS DATE:
MD Anderson research highlights for November 15, 2023
2023-11-15
HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Recent developments at MD Anderson include insights into the role of RNA-binding proteins in DNA damage repair, the functional role of a hidden microprotein in regulating colorectal cancer gene expression, immunotherapy combinations in gynecologic cancers, the benefits of preventive exercise in protecting ...
Exposure to air pollution in utero may affect reproductive system development
2023-11-15
From invisible wafts of diesel exhaust to sun-choking plumes of orange smoke, air pollution is known to damage respiratory well-being. Now, research from Rutgers suggests another reason to hold our breath: Polluted air also may hurt reproductive health.
In a study of air pollution data in relation to markers of reproductive development in infancy, Rutgers researchers found certain pollutants may negatively alter anogenital distance, a measure of prenatal exposure to hormones.
“These findings suggest air ...
Novel C. diff structures are required for infection, offer new therapeutic targets
2023-11-15
Iron storage “spheres” inside the bacterium C. diff — the leading cause of hospital-acquired infections — could offer new targets for antibacterial drugs to combat the pathogen.
A team of Vanderbilt researchers discovered that C. diff (Clostridioides difficile) produces the spheres, called ferrosomes, and that these structures are important for infection in an animal model. The findings, reported Nov. 15 in the journal Nature, are also a rare demonstration of a membrane-bound structure inside a pathogenic bacterium.
Bacteria have long been thought not to contain organelles ...
UK diabetes prevention program may have global impact
2023-11-15
A nationwide programme to reduce the risk of developing diabetes in the UK is proven beyond reasonable doubt to work, a new study reveals.
The positive effects observed in the NHS Diabetes Prevention Programme – the largest such project in the world helping people across the UK to lose weight and control their blood sugar levels – may have relevance globally for tackling the diabetes epidemic.
The Diabetes Prevention Programme (NHS DPP) in England referred adults with high risk of developing diabetes to lifestyle counselling for losing weight, encouraging physical activity, and other ...
James Webb Space Telescope detects water vapor, sulfur dioxide and sand clouds in the atmosphere of a nearby exoplanet
2023-11-15
A team of European astronomers, co-led by researchers from the Institute of Astronomy, KU Leuven, used recent observations made with the James Webb Space Telescope to study the atmosphere of the nearby exoplanet WASP-107b. Peering deep into the fluffy atmosphere of WASP-107b they discovered not only water vapour and sulfur dioxide, but even silicate sand clouds. These particles reside within a dynamic atmosphere that exhibits vigorous transport of material.
Astronomers worldwide are harnessing the advanced capabilities of the Mid-Infrared Instrument (MIRI) aboard the James Webb Space Telescope (JWST) to conduct groundbreaking observations of exoplanets – planets orbiting stars ...
New laser setup probes metamaterial structures with ultrafast pulses
2023-11-15
Metamaterials are products of engineering wizardry. They are made from everyday polymers, ceramics, and metals. And when constructed precisely at the microscale, in intricate architectures, these ordinary materials can take on extraordinary properties.
With the help of computer simulations, engineers can play with any combination of microstructures to see how certain materials can transform, for instance, into sound-focusing acoustic lenses or lightweight, bulletproof films.
But simulations can only take a design so far. To know for sure whether a metamaterial will stand up to expectation, physically testing them is a must. But there’s been no reliable way to push and pull ...
Pulling the plug on brain injury: manipulating fluid flows could save lives, improve recovery post-TBI
2023-11-15
Cerebral edema, the dangerous brain swelling that occurs after traumatic brain injury (TBI), can increase risk of death tenfold and significantly worsen prospects for recovery in brain function. In extreme cases, surgeons will remove a portion of the skull to relieve pressure, but this has significant risks and is not viable for the vast majority of TBI cases. Physicians have very few tools at their disposal that are effective in treating cerebral edema, which is one of the leading causes of in-hospital deaths, and is associated with long-term neurological disability.
New ...
Completion of recommended tests and referrals in telehealth vs in-person visits
2023-11-15
About The Study: The findings of this study suggest that rates of completion for 4,133 diagnostic tests and referrals (colonoscopies, cardiac stress tests, and dermatology referrals) were low for all visit types but worse when ordered during telehealth visits. Failure to close diagnostic loops presents a patient safety challenge in primary care that may be of particular concern during telehealth encounters.
Authors: Maelys J. Amat, M.D., M.B.A., of Beth Israel Deaconess Medical Center in Boston, is the corresponding author.
To ...
Neighborhood disadvantage and autism spectrum disorder in a population with health insurance
2023-11-15
About The Study: Children residing in more disadvantaged neighborhoods at birth had higher likelihood of autism spectrum disorder (ASD) diagnosis in a study that included 318,000 children with health insurance. Future research is warranted to investigate the mechanisms behind the neighborhood-related disparities in ASD diagnosis, alongside efforts to provide resources for early intervention and family support in communities with a higher likelihood of ASD.
Authors: Daniel A. Hackman, Ph.D., of the University of Southern California in Los Angeles, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(10.1001/jamapsychiatry.2023.4347)
Editor’s ...
Roaming seabirds need ocean-wide protection
2023-11-15
Seabirds roam far and wide in the Indian Ocean – so they need ocean-wide protection, new research shows.
All other oceans are known to contain “hotspots” where predators including seabirds feast on prey.
But the new study – by a team including Exeter, Heriot-Watt and Réunion universities, and ZSL – found no such concentrations in the Indian Ocean.
With seabirds facing numerous threats due to human activity, their survival depends on protecting the open ocean.
“Efforts are being made to protect key breeding colonies, but until now little was known about where Indian Ocean seabirds ...